NCT06975293 2026-04-17
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
STORM Therapeutics LTD
Phase 1/2 Recruiting
STORM Therapeutics LTD
Nanjing Immunophage Biotech Co., Ltd
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Sun Yat-sen University